Racial variations in treatment for glaucoma and cataract among Medicare recipients

Fang Wang, Jonathan C. Javitt, James M. Tielsch

Research output: Contribution to journalArticle

Abstract

Purpose: To identify the location of barriers to treatment for glaucoma and cataract among African-American Medicare beneficiaries. Methods: We examined the receipt of eye care in general and care for glaucoma and cataract in particular among black and white Medicare beneficiaries using 1991 Medicare physician claims data. Racial differences in treatment for glaucoma and cataract were examined both for the Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Results: Thirty percent of black beneficiaries and 45% of white Medicare beneficiaries used eye care services in 1991. After adjusting for the expected difference in prevalence, black beneficiaries were half as likely to be surgically treated for glaucoma compared to white beneficiaries, and 80% as likely for cataract. When the analysis was restricted to those using eye care services, blacks continued to have lower than expected rates of treatment for glaucoma (observed RR = 3.2, 95% confidence interval = 3.1-3.4 vs an expected RR of 4.3, 95% confidence interval = 3.5-5.4), but a higher rate of treatment for cataract (RR = 1.2, 95% confidence interval = 1.2-1.3). Among those with physician diagnosed glaucoma and cataract, blacks were more likely to undergo surgical treatment for these conditions than whites (RR = 1.5 for glaucoma, 95% confidence interval = 1.4-1.5; RR = 1.2 for cataract, 95% confidence interval = 1.2-1.3). Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Conclusion: Barriers to treatment for glaucoma and cataract among black Medicare beneficiaries involve primarily limitations in access to the eye care system. The undertreatment for glaucoma among black beneficiaries was reduced, but not eliminated, after removing the effect of unequal access to the eye care system.

Original languageEnglish (US)
Pages (from-to)89-100
Number of pages12
JournalOphthalmic Epidemiology
Volume4
Issue number2
StatePublished - 1997

Fingerprint

Medicare
Glaucoma
Cataract
Confidence Intervals
Therapeutics
Population
Physicians
African Americans

Keywords

  • African American
  • Cataract
  • Eye care utilization
  • Glaucoma
  • Medicare
  • Racial factors

ASJC Scopus subject areas

  • Ophthalmology
  • Epidemiology

Cite this

Racial variations in treatment for glaucoma and cataract among Medicare recipients. / Wang, Fang; Javitt, Jonathan C.; Tielsch, James M.

In: Ophthalmic Epidemiology, Vol. 4, No. 2, 1997, p. 89-100.

Research output: Contribution to journalArticle

Wang, F, Javitt, JC & Tielsch, JM 1997, 'Racial variations in treatment for glaucoma and cataract among Medicare recipients', Ophthalmic Epidemiology, vol. 4, no. 2, pp. 89-100.
Wang, Fang ; Javitt, Jonathan C. ; Tielsch, James M. / Racial variations in treatment for glaucoma and cataract among Medicare recipients. In: Ophthalmic Epidemiology. 1997 ; Vol. 4, No. 2. pp. 89-100.
@article{d38d4c81a99b460fba25bba530dbb631,
title = "Racial variations in treatment for glaucoma and cataract among Medicare recipients",
abstract = "Purpose: To identify the location of barriers to treatment for glaucoma and cataract among African-American Medicare beneficiaries. Methods: We examined the receipt of eye care in general and care for glaucoma and cataract in particular among black and white Medicare beneficiaries using 1991 Medicare physician claims data. Racial differences in treatment for glaucoma and cataract were examined both for the Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Results: Thirty percent of black beneficiaries and 45{\%} of white Medicare beneficiaries used eye care services in 1991. After adjusting for the expected difference in prevalence, black beneficiaries were half as likely to be surgically treated for glaucoma compared to white beneficiaries, and 80{\%} as likely for cataract. When the analysis was restricted to those using eye care services, blacks continued to have lower than expected rates of treatment for glaucoma (observed RR = 3.2, 95{\%} confidence interval = 3.1-3.4 vs an expected RR of 4.3, 95{\%} confidence interval = 3.5-5.4), but a higher rate of treatment for cataract (RR = 1.2, 95{\%} confidence interval = 1.2-1.3). Among those with physician diagnosed glaucoma and cataract, blacks were more likely to undergo surgical treatment for these conditions than whites (RR = 1.5 for glaucoma, 95{\%} confidence interval = 1.4-1.5; RR = 1.2 for cataract, 95{\%} confidence interval = 1.2-1.3). Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Conclusion: Barriers to treatment for glaucoma and cataract among black Medicare beneficiaries involve primarily limitations in access to the eye care system. The undertreatment for glaucoma among black beneficiaries was reduced, but not eliminated, after removing the effect of unequal access to the eye care system.",
keywords = "African American, Cataract, Eye care utilization, Glaucoma, Medicare, Racial factors",
author = "Fang Wang and Javitt, {Jonathan C.} and Tielsch, {James M.}",
year = "1997",
language = "English (US)",
volume = "4",
pages = "89--100",
journal = "Ophthalmic Epidemiology",
issn = "0928-6586",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Racial variations in treatment for glaucoma and cataract among Medicare recipients

AU - Wang, Fang

AU - Javitt, Jonathan C.

AU - Tielsch, James M.

PY - 1997

Y1 - 1997

N2 - Purpose: To identify the location of barriers to treatment for glaucoma and cataract among African-American Medicare beneficiaries. Methods: We examined the receipt of eye care in general and care for glaucoma and cataract in particular among black and white Medicare beneficiaries using 1991 Medicare physician claims data. Racial differences in treatment for glaucoma and cataract were examined both for the Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Results: Thirty percent of black beneficiaries and 45% of white Medicare beneficiaries used eye care services in 1991. After adjusting for the expected difference in prevalence, black beneficiaries were half as likely to be surgically treated for glaucoma compared to white beneficiaries, and 80% as likely for cataract. When the analysis was restricted to those using eye care services, blacks continued to have lower than expected rates of treatment for glaucoma (observed RR = 3.2, 95% confidence interval = 3.1-3.4 vs an expected RR of 4.3, 95% confidence interval = 3.5-5.4), but a higher rate of treatment for cataract (RR = 1.2, 95% confidence interval = 1.2-1.3). Among those with physician diagnosed glaucoma and cataract, blacks were more likely to undergo surgical treatment for these conditions than whites (RR = 1.5 for glaucoma, 95% confidence interval = 1.4-1.5; RR = 1.2 for cataract, 95% confidence interval = 1.2-1.3). Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Conclusion: Barriers to treatment for glaucoma and cataract among black Medicare beneficiaries involve primarily limitations in access to the eye care system. The undertreatment for glaucoma among black beneficiaries was reduced, but not eliminated, after removing the effect of unequal access to the eye care system.

AB - Purpose: To identify the location of barriers to treatment for glaucoma and cataract among African-American Medicare beneficiaries. Methods: We examined the receipt of eye care in general and care for glaucoma and cataract in particular among black and white Medicare beneficiaries using 1991 Medicare physician claims data. Racial differences in treatment for glaucoma and cataract were examined both for the Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Results: Thirty percent of black beneficiaries and 45% of white Medicare beneficiaries used eye care services in 1991. After adjusting for the expected difference in prevalence, black beneficiaries were half as likely to be surgically treated for glaucoma compared to white beneficiaries, and 80% as likely for cataract. When the analysis was restricted to those using eye care services, blacks continued to have lower than expected rates of treatment for glaucoma (observed RR = 3.2, 95% confidence interval = 3.1-3.4 vs an expected RR of 4.3, 95% confidence interval = 3.5-5.4), but a higher rate of treatment for cataract (RR = 1.2, 95% confidence interval = 1.2-1.3). Among those with physician diagnosed glaucoma and cataract, blacks were more likely to undergo surgical treatment for these conditions than whites (RR = 1.5 for glaucoma, 95% confidence interval = 1.4-1.5; RR = 1.2 for cataract, 95% confidence interval = 1.2-1.3). Medicare population as a whole and for identified eye care users. The results were compared to the expected value of black-white difference based on population prevalence data for each specific condition. Conclusion: Barriers to treatment for glaucoma and cataract among black Medicare beneficiaries involve primarily limitations in access to the eye care system. The undertreatment for glaucoma among black beneficiaries was reduced, but not eliminated, after removing the effect of unequal access to the eye care system.

KW - African American

KW - Cataract

KW - Eye care utilization

KW - Glaucoma

KW - Medicare

KW - Racial factors

UR - http://www.scopus.com/inward/record.url?scp=0030758767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030758767&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 89

EP - 100

JO - Ophthalmic Epidemiology

JF - Ophthalmic Epidemiology

SN - 0928-6586

IS - 2

ER -